Navigation Links
33rd Annual Hutch Holiday Gala Raises Millions for Cancer Immunotherapy Research
Date:12/8/2008

SEATTLE, Dec. 8 /PRNewswire/ -- Saturday's Hutch Holiday Gala raised more than $2.2 million for cancer and related disease research at Fred Hutchinson Cancer Research Center.

"Help the Hutch," a portion of the live auction during which guests raise their bid cards for specific contribution levels, brought in $1.2 million to be directed toward immunotherapy, through which clinicians harness a patient's immune system to battle cancer.

The black-tie Gala took place Dec. 6 from 5 to 10 p.m. at the Seattle Sheraton Hotel. Leading the "Help the Hutch" appeal was Dr. Lee Hartwell, president and director of the Hutchinson Center, who said donations made through the annual outreach event are essential to help scientists make discoveries that improve the future of human health.

"We are fortunate that the community recognizes the need for private support in the fight against cancer," Hartwell said. "Government grants simply do not provide the resources necessary to pilot new research ideas or bring new breakthroughs to patient care.

"Our science has demonstrated the potential of immunotherapy to change the face of cancer treatment," he said. "Because of the resources required to develop these novel therapies, we have had to move slowly. Yet our extraordinary success with these therapies and new information about how to extend their results has brought us to the point where a major acceleration of this work is needed."

Funds raised through the "Help the Hutch" portion of the Gala will be used for an expansion of immunotherapy clinical trials to test their impact on normally fatal late stage disease for a variety of cancers, Hartwell said.

An example of the Center's success in immunotherapy research was reported in the June 19 issue of the New England Journal of Medicine, in which a team led by Cassian Yee, M.D., an associate member of the Clinical Research Division, described the first successful use of a human patient's cloned infection-fighting T cells as the sole therapy to put advanced melanoma tumors into long-term remission. A type of white blood cell was removed from a 52-year-old man who had metastatic Stage 4 melanoma; more such cells were grown in the lab, then infused into the patient. Two months later the man's tumors were gone and he remained disease-free two years later, when he was last checked. Yee and other Center researchers are now expanding clinical trials that use T-cell therapy to treat advanced tumors.

At the Saturday night Gala, patrons also bid for exclusive auction packages including a zero-gravity flight with space and science celebrities including Bonnie Dunbar and Charles Simonyi and Dr. Hartwell, which sold at $7,500 per person for a total of $157,500; an Italian sojourn at Villa Madalena, $20,000; a U.S. Open package, $16,000; VIP tickets to the Country Music Awards, $14,000; and an exclusive July 4 fireworks party on a rooftop deck at the Hutchinson Center's South Lake Union campus, $13,000.

The evening's festivities included the presentation of the Grace Heffernan Arnold Guild's 2008 Distinguished Community Service Award to the Swanson family. Accepting the award were Gerry and Gloria Swanson, who have been involved with the community for 30 years through such causes as the Hutchinson Center, Seattle Children's and United Way. The couple's children and their spouses also support a variety of organizations and, in combination with a family fund at Children's, established the Swanson Family Endowed Chair in Pediatric Bone Marrow and Transplantation Research, a chair held by the Hutchinson Center's Dr. Jean Sanders.

Presented by the Grace Heffernan Arnold Guild and the Hutch Holiday Gala board of trustees, the Hutch Holiday Gala featured live and silent auctions and an elegant dinner with hundreds of business and community leaders in attendance. Through the past three decades the Gala has raised more than $60 million in support of key research initiatives and patient and family programs at the Hutchinson Center.

To learn more about the Hutch Holiday Gala, call 206-667-5423 or visit http://www.hutchgala.com. More information about the Hutchinson Center is available at http://www.fhcrc.org.

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit http://www.fhcrc.org.

     CONTACT
     Christi Ball Loso
     206-667-5215
     closo@fhcrc.org

'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Houston Mother Who Nearly Lost Her Daughter to Influenza Joins American Lung Associations Faces of Influenza Campaign to Promote Annual Vaccination
2. Sacramento Mother Dee Dee Abdur-Rahim and Deputy District Attorney Robin Shakely Join the American Lung Associations Faces of Influenza Campaign to Promote Annual Vaccination
3. SCAIs Annual Fall Fellows Course Prepares New Interventional Cardiologists to Work in the Field
4. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
5. Late-breaking data to be presented at the American Society of Hematology Annual Meeting
6. Hologic to Present at the J.P. Morgan 27th Annual Healthcare Conference
7. REGiMMUNE to present GvHD data at the 50th ASH Annual Meeting
8. Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto
9. How to Ensure Your Companys Survival: Leaders to Discuss at the 11th Annual Customer Experience Conference in Las Vegas
10. MaxCyte to Present Targeted Cancer Immunotherapy Product at 50th Annual Meeting of the American Society of Hematology
11. Nu Skin Enterprises Offers 2009 Guidance During Annual Investor Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Compliancy Group LLC is pleased ... professionals throughout the country. The Guard was specifically designed to handle each element ... training, regulatory updates, and compliance coaching. , In addition to meeting the compliance ...
(Date:2/10/2016)... SAN FRANCISCO, Calif. (PRWEB) , ... February 10, 2016 , ... ... category: Best Water Brand. There were three leading bottled water brand owners that topped ... edge services that enhance connectivity and optimize conversion. The premier brand was Tibet 5100, ...
(Date:2/10/2016)... ... 2016 , ... Ongoing news of the ravages of traumatic brain injury (TBI) ... survey that takes a closer look at cases of TBI being managed by their ... TBI among the aging population, and identifies the challenges associated with their care. , ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Gout is ... and brings pain that is often severe, with intense swelling and redness. It is ... eight million people, but older adults are the most susceptible, according to the February ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The Association ... inspirational speaker Jan Fox will serve as keynote speaker at the organization’s 2016 ... with tools to more effectively communicate with their own organizational staff and leadership. ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016 Urologix, the market leader for in-office ... Prostatic Hyperplasia (BPH), announces new private ownership and is ... medical device industry veteran of more than 20 years, ... Plymouth, Minn. The ... and Prostiva® RF Therapy, will continue to be broadly ...
(Date:2/10/2016)... 2016 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... it has filed a patent application directed to the ... --> --> The new ... Ceplene (histamine dihydrochloride) in combination with immune checkpoint inhibitors. ... efficacy of Ceplene and IL-2 therapy in patients with ...
(Date:2/10/2016)... Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: ... 1-for-100 reverse split of its issued and outstanding shares ... on Thursday, February 11, 2016. The Company,s common stock ... number 76303T308 and temporary ticker symbol "RCHAD". After 20 ... the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology: